- Market Capitalization, $K 61,791
- Shares Outstanding, K 33,582
- Annual Sales, $ 52,610 K
- Annual Income, $ -66,250 K
- 60-Month Beta 2.46
- Price/Sales 1.20
- Price/Cash Flow N/A
- Price/Book N/A
|Period||Period Low||Period High||Performance|
| || |
-1.71 (-44.76%)since 03/06/20
| || |
-3.73 (-63.87%)since 01/06/20
| || |
-4.44 (-67.79%)since 04/05/19
Houston, Texas--(Newsfile Corp. - March 17, 2020) - Memgen, a private biotechnology company developing innovative immuno-oncology drugs, announced today that its Board of Directors has appointed Gregory...
Companies In The News Are: POAI, APT, AQST, TACO
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -6.67% and 4.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?...
WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Wednesday reported a loss of $12.6 million in its fourth quarter.
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Momentum Stocks to Buy for December 9th
Companies In The News Are:
Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.
Aquestive Therapeutics (AQST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Companies In The News Are: WW, VNTR, PLT, AQST